ID   UM-HACC-6
AC   CVCL_E7S0
SY   University of Michigan-Human Adenoid Cystic Carcinoma-14
RX   PubMed=38971694;
CC   Population: Caucasian.
CC   Doubling time: 54 hours (PubMed=38971694).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
ST   Source(s): PubMed=38971694
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 14,19
ST   D21S11: 32,33.2
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 13
ST   Penta E: 13,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=38971694; DOI=10.1016/j.oooo.2024.06.005; PMCID=PMC11827064;
RA   Warner K.A., Herzog A.E., Sahara S., Nor F., Castilho R.M., Demirci H.,
RA   Chepeha D.B., Polverini P.J., Nor J.E.;
RT   "Establishment and characterization of cMYB-expressing human salivary
RT   adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and
RT   matching patient-derived xenograft model (UM-PDX-HACC-14).";
RL   Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 138:516-531(2024).
//